Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells (Q33630829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

title

Pre-clinical evaluation of cyclin-dependent kinase 2 and 1 inhibition in anti-estrogen-sensitive and resistant breast cancer cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

N Johnson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

J Bentley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

L-Z Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

D R Newell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

C N Robson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

G I Shapiro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

English

0 references

publication date

15 December 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

15 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

volume

102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

page(s)

342-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells

15 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

p21 Inhibits Cdk1 in the absence of Cdk2 to maintain the G1/S phase DNA damage checkpoint.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Combined depletion of cell cycle and transcriptional cyclin-dependent kinase activities induces apoptosis in cancer cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Cyclin-dependent kinase 2 functions in normal DNA repair and is a therapeutic target in BRCA1-deficient cancers

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimization

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Cdk2 knockout mice are viable

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Endocrine-responsive breast cancer and strategies for combating resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Designing inhibitors of cyclin-dependent kinases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

New colorimetric cytotoxicity assay for anticancer-drug screening

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Cdk inhibitor p27Kip1 and hormone dependence in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Tip60 is a nuclear hormone receptor coactivator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

E2F activity is biphasically regulated by androgens in LNCaP cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

A comparative study of genome-wide SNP, CGH microarray and protein expression analysis to explore genotypic and phenotypic mechanisms of acquired antiestrogen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Differential response to phytoestrogens in endocrine sensitive and resistant breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

Proliferation of cancer cells despite CDK2 inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605479

p27(Kip1) induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2816653

Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20010939

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Discovery of a regulatory motif that controls the exposure of specific upstream cyclin-dependent kinase sites that determine both conformation and growth suppressing activity of pRb

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20010939

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/SJ.BJC.6605479

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

15 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20010939%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

PubMed publication ID

20010939

1 reference